drug
as of 2026-07-01GSK1144814
at a glance
small molecule
Pre-approval / investigational in the US
Developed by GlaxoSmithKline
3 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
3
A Repeat Dose Positron Emission Tomography Study With GSK1144814
NCT01209039Phase 1Completed
Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Subjects
NCT01090440Phase 1Completed
First Time in Human Study (FTIH) With Positron Emission Tomography (PET)
NCT01381419Phase 1Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication